IL17A and cancer: Cytokines, such as IL-6, IL-17 and IL-23 produced by the NF-κB or STAT3 signaling pathway, induce cancer proliferation and metastasis by promoting TAMs to inhibit a cytotoxic T cell response [115] (Figure 4).